Cargando…

Valproic Acid Neuroprotection in the 6-OHDA Model of Parkinson's Disease Is Possibly Related to Its Anti-Inflammatory and HDAC Inhibitory Properties

Parkinson's disease is a neurodegenerative disorder where the main hallmark is the dopaminergic neuronal loss. Besides motor symptoms, PD also causes cognitive decline. Although current therapies focus on the restoration of dopamine levels in the striatum, prevention or disease-modifying therap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ximenes, José Christian Machado, Neves, Kelly Rose Tavares, Leal, Luzia Kalyne A. M., do Carmo, Marta Regina Santos, Brito, Gerly Anne de Castro, Naffah-Mazzacoratti, Maria da Graça, Cavalheiro, Ésper Abrão, Viana, Glauce Socorro de Barros
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437346/ https://www.ncbi.nlm.nih.gov/pubmed/26317011 http://dx.doi.org/10.1155/2015/313702

Ejemplares similares

Pentoxifylline Neuroprotective Effects Are Possibly Related to Its Anti-Inflammatory and TNF-Alpha Inhibitory Properties, in the 6-OHDA Model of Parkinson's Disease
por: Neves, Kelly Rose Tavares, et al.
Publicado: (2015)

Neuroprotective Properties of the Standardized Extract from Camellia sinensis (Green Tea) and Its Main Bioactive Components, Epicatechin and Epigallocatechin Gallate, in the 6-OHDA Model of Parkinson's Disease
por: Bitu Pinto, Natália, et al.
Publicado: (2015)

Indomethacin can downregulate the levels of inflammatory mediators in the hippocampus of rats submitted to pilocarpine-induced status epilepticus
por: Vieira, Michele Juliane, et al.
Publicado: (2014)

Exercise-induced hippocampal anti-inflammatory response in aged rats
por: Gomes da Silva, Sérgio, et al.
Publicado: (2013)

Melatonin treatment decreases c-fos expression in a headache model induced by capsaicin
por: Tanuri, Fabiano C., et al.
Publicado: (2009)

Hormonal and biochemical changes in female Proechimys guyannensis, an animal model of resistance to pilocarpine-induced status epilepticus
por: Sanabria, Viviam, et al.
Publicado: (2020)

Anti-inflammatory effects and possible mechanism of action of lupeol acetate isolated from Himatanthus drasticus (Mart.) Plumel
por: Lucetti, Daniel L, et al.
Publicado: (2010)

Omega-3 Fatty Acids: Possible Neuroprotective Mechanisms in the Model of Global Ischemia in Rats
por: Nobre, Maria Elizabeth Pereira, et al.
Publicado: (2016)

Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons
por: Ji Yuan, Wen, et al.
Publicado: (2008)

Behavioral and Neurochemical Effects of Alpha-Lipoic Acid in the Model of Parkinson's Disease Induced by Unilateral Stereotaxic Injection of 6-Ohda in Rat
por: de Araújo, Dayane Pessoa, et al.
Publicado: (2013)

HDAC inhibitor valproic acid upregulates CAR in vitro and in vivo
por: Segura-Pacheco, Blanca, et al.
Publicado: (2007)

Pharmacognostical Analysis and Protective Effect of Standardized Extract and Rizonic Acid from Erythrina velutina against 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells
por: Silva, Aline H., et al.
Publicado: (2016)

Neuroprotective Properties of a Standardized Extract from Myracrodruon urundeuva Fr. All. (Aroeira-Do-Sertão), as Evaluated by a Parkinson's Disease Model in Rats
por: Calou, Iana, et al.
Publicado: (2014)

Neuroprotective effect of Spirulina fusiform and amantadine in the 6-OHDA induced Parkinsonism in rats
por: Chattopadhyaya, I, et al.
Publicado: (2015)

Tetrahydroxystilbene Glucoside Produces Neuroprotection against 6-OHDA-Induced Dopamine Neurotoxicity
por: Huang, Chun, et al.
Publicado: (2018)

Neuroprotective effect and mechanism of baicalin on Parkinson’s disease model induced by 6-OHDA
por: Tu, Li, et al.
Publicado: (2019)

HDAC Inhibition by Valproic Acid Induces Neuroprotection and Improvement of PD-like Behaviors in LRRK2 R1441G Transgenic Mice
por: Kim, Taewoo, et al.
Publicado: (2019)

Inhibition of leukemic cells by valproic acid, an HDAC inhibitor, in xenograft tumors
por: Zhang, Zhihua, et al.
Publicado: (2013)

Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19
por: Pitt, Bertram, et al.
Publicado: (2021)

Anticholinergics: A potential option for preventing posttraumatic epilepsy
por: Sanabria, Viviam, et al.
Publicado: (2023)

Exposure to valproic acid (VPA) reproduces hdac1 loss of function phenotypes in zebrafish
por: Jones, Alec A., et al.
Publicado: (2023)

Nrf2 Signaling Contributes to the Neuroprotective Effects of Urate against 6-OHDA Toxicity
por: Zhang, Ning, et al.
Publicado: (2014)

Erratum to: Neuroprotective effect of Spirulina fusiform and amantadine in the 6-OHDA induced Parkinsonism in rats
por: Chattopadhyaya, I., et al.
Publicado: (2015)

Neuroprotective Effect of Valproic Acid on Salicylate-Induced Tinnitus
por: Song, Anji, et al.
Publicado: (2021)

Hypoglycemic and anti-lipemic effects of the aqueous extract from Cissus sicyoides
por: Viana, Glauce SB, et al.
Publicado: (2004)

Neuroprotective activity of Stereospermum suaveolens DC against 6-OHDA induced Parkinson's disease model
por: Shalavadi, M. H., et al.
Publicado: (2012)

Neuroprotective Effect of 1,4-Naphthoquinones in an In Vitro Model of Paraquat and 6-OHDA-Induced Neurotoxicity
por: Menchinskaya, Ekaterina, et al.
Publicado: (2021)

The Wound Healing Property of N-Methyl-(2S,4R)-trans-4-Hydroxy-L-Proline from Sideroxylon obtusifolium is Related to its Anti-Inflammatory and Antioxidant Actions
por: de Aquino, Pedro Everson Alexandre, et al.
Publicado: (2019)

Gut-microbiome-brain axis: the crosstalk between the vagus nerve, alpha-synuclein and the brain in Parkinson’s disease
por: Claudino dos Santos, Júlio César, et al.
Publicado: (2023)

Valproic Acid and Other HDAC Inhibitors Upregulate FGF21 Gene Expression and Promote Process Elongation in Glia by Inhibiting HDAC2 and 3
por: Leng, Yan, et al.
Publicado: (2016)

Propolis as a Potential Disease-Modifying Strategy in Parkinson’s disease: Cardioprotective and Neuroprotective Effects in the 6-OHDA Rat Model
por: C. Gonçalves, Valeria, et al.
Publicado: (2020)

Anacardium microcarpum Promotes Neuroprotection Dependently of AKT and ERK Phosphorylation but Does Not Prevent Mitochondrial Damage by 6-OHDA
por: Martins, Illana Kemmerich, et al.
Publicado: (2018)

Chaperone Sigma1R mediates the neuroprotective action of afobazole in the 6-OHDA model of Parkinson’s disease
por: Voronin, Mikhail V., et al.
Publicado: (2019)

Curcumin reverses neurochemical, histological and immuno-histochemical alterations in the model of global brain ischemia
por: de Alcântara, Glaura Fernandes Teixeira, et al.
Publicado: (2016)

The Neuroprotective Effect of Treatment of Valproic Acid in Acute Spinal Cord Injury
por: Yu, Song-Hee, et al.
Publicado: (2012)

Valproic acid potentiates curcumin-mediated neuroprotection in lipopolysaccharide induced rats
por: Zaky, Amira, et al.
Publicado: (2014)

Reduction of vascular reactivity in rat aortas following pilocarpine-induced status epilepticus
por: Nunes, Karolini Zuqui, et al.
Publicado: (2023)

Sudden Cardiac Death in the Young: Could Epilepsy be Involved?
por: Scorza, Fulvio Alexandre, et al.
Publicado: (2010)

Astrocytic Expression of GSTA4 Is Associated to Dopaminergic Neuroprotection in a Rat 6-OHDA Model of Parkinson’s Disease
por: Jewett, Michael, et al.
Publicado: (2017)

The Neuroprotective Effects of the CB2 Agonist GW842166x in the 6-OHDA Mouse Model of Parkinson’s Disease
por: Yu, Hao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m1k37hrclvm2sb0clqldltj33d